Defining lymphoplasmacytic lymphoma: Does MYD88 L265P define a pathologically distinct entity among patients with an IgM paraprotein and bone marrow-based low-grade b-cell lymphomas with plasmacytic differentiation?

Hong Fang, Prashant Kapoor, Wilson I. Gonsalves, Lori A. Frederick, David Viswanatha, Matthew T. Howard, Rong He, William G. Morice, Ellen D. McPhail, Patricia T. Greipp, Stephen M. Ansell, Robert A. Kyle, Morie A. Gertz, Jonas Paludo, Jithma Abeykoon, Rebecca L. King

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Defining lymphoplasmacytic lymphoma: Does MYD88 L265P define a pathologically distinct entity among patients with an IgM paraprotein and bone marrow-based low-grade b-cell lymphomas with plasmacytic differentiation?'. Together they form a unique fingerprint.

Medicine & Life Sciences